Excerpt: Americans on average paid 81 percent more for patented brand-name drugs last year than buyers in Canada and six western European countries, .... That gap represents a significant increase from 2000, when the cost differential between the United States and the seven other countries was 60 percent. The study by Boston University's School of Public Health relied on comparative data on the costs of drugs in the United States and European countries released earlier this month[.]  MORE >>